TRK-820: Uremic PruritusAC-100AC-200


Pipeline Overview

Acologix has several key product development programs in the osteo-renal area at various stages of clinical and preclinical development. The most advanced program in the renal area is in Phase 3 and product approval stages in and outside of the U.S., respectively. The most advanced program in the hard tissue area is at the Phase 2 or pre-Phase 2 clinical development stage in the U.S., depending on the indication. The third program is at the preclinical stage seeking the advancement toward clinical development. Acologix established its product pipeline through academic collaborations and in-licensing. The Company plans to expand its pipeline continuously by adding new product candidates in the osteo-renal and related areas.

   

 
Product Portfolio
Drug Preclin Phase 1 Phase 2 Phase 3 NDA
AC-820
Uremic Pruritus  
Other Itching Indications      
AC-100
Dental / Oral Care Applications    
Cartilage/Bone Applications      
AC-200
Renal Osteodystrophy        
Note: AC-820 was approved for uremic pruritus by the Japanese Regulatory Agency in January 2009.
 
Home | About Acologix | Pipeline | Investor Relations | Partnering | News | Contact | Careers | Sitemap | Disclaimer
© 2009 Acologix, Inc.  All rights reserved.
Contact Acologix Careers Sitemap Acologix Homepage